Topic: What issues do you need to consider when designing the finished and marketed product comprising a tablet containing a non-sedating anti-histami
Topic: Mental Health (drug induced psychosis and recovery)
August 23, 2020The Endocrine system: diseases and age-related changes
August 23, 2020Topic: What issues do you need to consider when designing the finished and marketed product comprising a tablet containing a non-sedating anti-histami
Order Description
What issues do you need to consider when designing the finished and marketed product comprising a tablet containing a non-sedating anti-histamine?
The drug has T1/2 = 16h and the adult dose will be 2mg of active pharmaceutical ingredient, once daily.
Given the need for a liquid formulation for children (between the ages of 2 and 12), which factors need to be taken into consideration when designing that finished product?
Word limit: 800 -1200
